PERIMETER SOLUTIONS, INC. (PRM) Free cash flow
- Free cash flow · 12 months (USD): Value $97.10M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 12.83%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $97.10M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $127.64M − $30.54M ≈ $97.10M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 12.83% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $97.10M ÷ $757.07M × 100 ≈ 12.83% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $127.64M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.38× | Operating cash flow / net income. Period ending 2026-06-30. $127.64M ÷ $-339.62M ≈ -0.38× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 127.64M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 30.54M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 97.10M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 757.07M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -339.62M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $97.10M | (m) | $127.64M | $30.54M | (m) | $757.07M | (m) | $-339.62M | (m) | (m) | 12.83% | -0.38× |
| 2026-03-31 | $94.86M | (m) | $125.44M | $30.58M | (m) | $705.90M | (m) | $-190.15M | (m) | (m) | 13.44% | -0.66× |
| 2025-12-31 | $208.56M | (m) | $238.15M | $29.59M | (m) | $652.86M | (m) | $-206.37M | (m) | (m) | 31.95% | -1.15× |
| 2025-09-30 | $184.50M | (m) | $213.56M | $29.06M | (m) | $636.34M | (m) | $78.03M | (m) | (m) | 28.99% | 2.74× |
| 2025-06-30 | $169.95M | (m) | $197.86M | $27.91M | (m) | $609.32M | (m) | $79.53M | (m) | (m) | 27.89% | 2.49× |
| 2025-03-31 | $190.56M | (m) | $209.35M | $18.79M | (m) | $573.95M | (m) | $133.34M | (m) | (m) | 33.20% | 1.57× |
| 2024-12-31 | $172.86M | (m) | $188.39M | $15.53M | (m) | $560.97M | (m) | $-5.91M | (m) | (m) | 30.81% | -31.90× |
| 2024-09-30 | $192.93M | (m) | $204.80M | $11.88M | (m) | $534.19M | (m) | $-163.32M | (m) | (m) | 36.12% | -1.25× |
| 2024-06-30 | $74.29M | (m) | $84.55M | $10.26M | (m) | $388.43M | (m) | $-54.87M | (m) | (m) | 19.13% | -1.54× |
| 2024-03-31 | $26.06M | (m) | $34.59M | $8.53M | (m) | $337.29M | (m) | $-24.50M | (m) | (m) | 7.73% | -1.41× |
| 2023-12-31 | $-9.24M | (m) | $193.00K | $9.44M | (m) | $322.11M | (m) | $67.49M | (m) | (m) | -2.87% | 0.00× |
| 2023-09-30 | $-16.44M | (m) | $-7.22M | $9.22M | (m) | $303.93M | (m) | $20.37M | (m) | (m) | -5.41% | -0.35× |
| 2023-06-30 | $-32.74M | (m) | $-23.76M | $8.98M | (m) | $321.78M | (m) | $107.31M | (m) | (m) | -10.17% | -0.22× |
| 2023-03-31 | $-10.65M | (m) | $-892.00K | $9.76M | (m) | $346.61M | (m) | $64.23M | (m) | (m) | -3.07% | -0.01× |
| 2022-12-31 | $-48.78M | (m) | $-40.17M | $8.61M | (m) | $360.50M | (m) | $91.76M | (m) | (m) | -13.53% | -0.44× |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-11-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $63.33M | (m) | $70.83M | $7.50M | (m) | $339.58M | (m) | $24.25M | (m) | (m) | 18.65% | 2.92× |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-9.16M | (m) | $-305.00K | $8.86M | (m) | $239.31M | (m) | $-42.04M | (m) | (m) | -3.83% | 0.01× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BALCHEM CORP (BCPC) | United States | $5.347B | 32.84 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| Solstice Advanced Materials Inc. (SOLS) | United States | $8.905B | 67.02 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |